Targeted Activation of Peroxisome Proliferator-activated Receptor γ (PPARγ) Rapidly Suppresses Inflammation Through Inhibition of Toll-like Receptor 4/nuclear Factor-κB (TLR4/NF-κB) Pathway and Further Shifts Advanced Atheroma into a Stable Phenotype